2126 | Complete JW (Cayman) Therapeutics Co. Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
JW (Cayman) Therapeutics Co. Ltd. is a clinical stage cell therapy company, which focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. The company was founded by Yi Ping Li on September 6, 2017 and is headquart...
JW (Cayman) Therapeutics Co. Ltd * (Incorporated in the Cayman Islands with limited liability) Stock Code: 2126 Annual Report * Contents 2 Corporate Information 4 Chairman's Statement 7 Financial Highlights 11 Business Highlights 14 Management Discussion and Analysis 41 Directors and Senior Management...
Listed on the main board of the Hong Kong Exchanges and Clearing Limited, stock code 2126.HK 2021 Sep Became the market authorization holder (MAH) for cell therapy product, and entered commercial stage 2022 Nov JW Therapeutics’ cell immunotherapy drugs have successfully benefited 300 Chinese patien...
Shanghai, China, March 26, 2020– JW Therapeutics (stock code: 2126.HK), a leading cellular immunotherapy company, today announced 2020 annual results. Business Highlights 2020 was a transformative year in our Company’s history. In June 2020, we submitted a new drug application (NDA) to the...
Download JW (Cayman) Therapeutics Co. Ltd. stock data: historical 2126 stock prices from MarketWatch.
Cautionary Statement required by Rule 18A.05 of the Rules Governing the Listing of Securities of The Stock Exchange of Hong Kong Limited: JW Therapeutics cannot guarantee that it will be able to develop, or ultimately market Relmacabtagene autoleucel ("relma-cel") successfully. Shareholders and...
纳斯达克综合指数中表现最佳的股票为Avenue Therapeutics Inc (NASDAQ:ATXI),上涨106.25%,收于7.26;思享无限 (NASDAQ:SJ)收盘时涨47.90%,报收2.47;X4 Pharmaceuticals Inc (NASDAQ:XFOR)上升40.18%,收盘价为1.25。 第三方广告。非Investing.com产品或...
M Lordkipanidzé,JG Diodati,C Pharand - 《Pharmacology & Therapeutics》 被引量: 135发表: 2009年 An Application of Value Stream Mapping In Automotive Industry: A Case Study The process is analysed foropportunity to drastically reduce and simplify it to the fewestactions necessary. By reducing wa...
最高發售價 : 每股股份23.80港元,另加1.0%經紀佣金,0.0027%證監會交易徵費及0.005% 聯交所交易費(申請時以港元繳足 ,可予退還) Nominal value : US$0.00001 per Share 面值 : 每股股份0.00001美元 Stock code : 2126 股份代號 : 2126 Please read carefully the prospectus of JW (Cayman) Therapeutics Co. ...